Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (33 ops.)
Latest filing published 30 May 2024 for Inhibrx, Inc., €9.5M.
Filing timeline
BuySaleBrendan P. Eckelman
Insider track record
Disclosed buys
0
Disclosed sells
33
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Brendan P. Eckelman: trading record in brief
Brendan P. Eckelman (senior executive) discloses dealings in 2 companies, chiefly Inhibrx, Inc. and Inhibrx Biosciences, Inc. Over a trading history stretching from 4 December 2020 to 30 May 2024, the count stands at 45 filings.
No open-market purchase appears, only 33 sales worth €18.3M. Outside the open market, there are 3 share grants. Since January 2024: no purchases and 1 sale on the market.
On 30 May 2024 came the latest disclosure, a transaction for €48.1M in Inhibrx, Inc. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Brendan P. Eckelman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
300,000 shares@ US$34.3066.1% of flowCommon StockSEC:0000950142-24-001497:0
433,888 sharesCommon StockSEC:0000950142-24-001490:0
39,600 shares@ US$24.20076.3% of flowCommon StockSEC:0001739614-23-000016:0
13,449 shares@ US$24.29252.1% of flowCommon StockSEC:0001739614-23-000012:0
22,213 shares@ US$23.4123.4% of flowCommon StockSEC:0001739614-23-000006:0
20,927 shares@ US$26.83483.7% of flowCommon StockSEC:0001739614-22-000128:0
27,651 shares@ US$33.3356.5% of flowCommon StockSEC:0001739614-22-000114:0
1,448 shares@ US$24.66880.2% of flowCommon StockSEC:0001739614-22-000105:0
160,000 shares0Common StockSEC:0001739614-22-000097:0
37,507 shares@ US$14.8573.9% of flowCommon StockSEC:0001739614-22-000095:0
24,500 shares@ US$17.6993.0% of flowCommon StockSEC:0001739614-22-000077:0
40,000 shares@ US$17.174.7% of flowCommon StockSEC:0001739614-22-000073:0
400 shares@ US$25.040.1% of flowCommon StockSEC:0001739614-22-000039:0
13 of 13 declarations
